Genomics in primary care practice

Primary Care - Clinics in Office Practice

Volumn 41, Issue 2, 2014, Pages 421-435

  Teng, Kathryn ^a   Acheson, Louise S ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Ancestry; Family health history; Genomic; Preventive care; Primary care; Value

Indexed keywords

DNA DETERMINATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC COUNSELING; GENETIC RISK; GENOMICS; HEALTH EDUCATION; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; RACE; REVIEW; ANCESTRY GROUP; ETHNIC GROUP; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FAMILY HEALTH; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 84900013871     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2014.02.012     Document Type: Review

References (74)

1. National health expenditures and selected economic indicators, levels and annual percent change: calendar years 2006-2021 table 1. 2012. Available at:. Accessed August 8, 2013. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2011PDF.pdf.
2. US Preventive Services Task Force Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005, 143(5):355-361.
3. Berg A.O. The CDC's EGAPP initiative: evaluating the clinical evidence for genetic tests. Am Fam Physician 2009, 80(11):1218.
4. 23andMe launches first national TV campaign. 2013. Available at:. Accessed August 14, 2013. http://mediacenter.23andme.com/press-releases/poh_ad_campaign/.
5. Bloss C.S., Schork N.J., Topol E.J. Effect of direct-to-consumer genomewide profiling to assess disease risk. NEngl J Med 2011, 364:524-534.
6. Bloss C.S., Wineinger N.E., Darst B.F., et al. Impact of direct-to-consumer genomic testing at long term follow-up. JMed Genet 2013, 50(6):393-400.
7. Kaphingst K.A., McBride C.M., Wade C., et al. Patients' understanding of and responses to multiplex genetic susceptibility test results. Genet Med 2012, 14(7):681-687.
8. Powell K.P., Christianson C.A., Cogswell W.A., et al. Educational needs of primary care physicians regarding direct-to-consumer genetic testing. JGenet Couns 2012, 21(3):469-478.
9. Veenstra D.L., Piper M., Haddow J.E., et al. Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update. Genet Med 2013, 15(1):14-24.
10. Doerr M., Teng K. Family history: still relevant in the genomics era. Cleve Clin J Med 2012, 79(5):331-336.
11. Dunlop K., Barlow-Stewart K., Giffin M. Family health history: a role in prevention. Aust Fam Physician 2010, 39(10):793-794.
12. Martin A.J., Lord S.J., Verry H.E., et al. Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis. Med J Aust 2013, 198(10):546-550.
13. Sud R., Roy B., Emerson J., et al. Associations between family history of cardiovascular disease, knowledge of cardiovascular disease risk factors and health behaviours. Aust J Prim Health 2013, 19(2):119-123.
14. Zlot A.I., Valdez R., Han Y., et al. Influence of family history of cardiovascular disease on clinicians' preventive recommendations and subsequent adherence of patients without cardiovascular disease. Public Health Genomics 2010, 13(7-8):457-466.
15. Zlot A.I., Bland M.P., Silvey K., et al. Influence of family history of diabetes on health care provider practice and patient behavior among nondiabetic Oregonians. Prev Chronic Dis 2009, 6(1):A27.
16. Ruffin M.T., Nease D.E., Sen A., et al. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 2011, 9(1):3-11.
17. Wijdenes M., Henneman L., Qureshi N., et al. Using web-based familial risk information for diabetes prevention: a randomized controlled trial. BMC Public Health 2013, 13:485.
18. Bronner K., Mesters I., Weiss-Meilnik A., et al. Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer?. Fam Cancer 2013, 12:629-637.
19. Lin O.S., Gluck M., Nguyen M., et al. Screening patterns in patients with a family history of colorectal cancer often do not adhere to national guidelines. Dig Dis Sci 2013, 58(7):1841-1848.
20. Walter F.M., Emery J. 'Coming down the line'-patients' understanding of their family history of common chronic disease. Ann Fam Med 2005, 3(5):405-414.
21. Acheson L.S., Wiesner G.L., Zyzanski S.J., et al. Family history-taking in community family practice: implications for genetic screening. Genet Med 2000, 2(3):180-185.
22. Scheuner M.T., de Vries H., Kim B., et al. Are electronic health records ready for genomic medicine?. Genet Med 2009, 11(7):510-517.
23. Qureshi N., Wilson B., Santaguida P., et al. Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep) 2007, (159):1-84.
24. Kannry J., Williams M.S. The undiscovered country: the future of integrating genomic information into the EHR. Genet Med 2013, 15(10):842-845.
25. Berg A.O., Baird M.A., Botkin J.R., et al. National Institutes of Health State-of-the-Science Conference Statement: family history and improving health. Ann Intern Med 2009, 151(12):872-877.
26. Qureshi N., Wilson B., Santaguida P., et al. Family history and improving health. Evid Rep Technol Assess (Full Rep) 2009, (186):1-135.
27. Emery J., Morris H., Goodchild R., et al. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 2007, 97(4):486-493.
28. Qureshi N., Armstrong S., Dhiman P., et al. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: amatched-pair, cluster randomized trial. Ann Intern Med 2012, 156(4):253-262.
29. Walter F.M., Prevost A.T., Birt L., et al. Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. Br J Gen Pract 2013, 63(611):e393-e400.
30. Scheuner M.T., Hamilton A.B., Peredo J., et al. Acancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet Med 2014, 16:60-69.
31. Biswas S., Atienza P., Chipman J., et al. Simplifying clinical use of the genetic risk prediction model BRCAPRO. Breast Cancer Res Treat 2013, 139(2):571-579.
32. Do C.B., Hinds D.A., Francke U., et al. Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genet 2012, 8(10):e1002973.
33. Hindorff L.A., Sethupathy P., Junkins H.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106(23):9362-9367.
34. Viera A.J. Odds ratios and risk ratios: what's the difference and why does it matter?. South Med J 2008, 101(7):730-734.
35. Yoon P.W., Scheuner M.T., Khoury M.J. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003, 24(2):128-135.
36. Hemminki K., Sundquist J., Bermejo J.L. How common is familial cancer?. Ann Oncol 2008, 19(1):163-167.
37. Wilson B.J., Carroll J.C., Allanson J., et al. Family history tools in primary care: does one size fit all?. Public Health Genomics 2012, 15(3-4):181-188.
38. Reid G.T., Walter F.M., Brisbane J.M., et al. Family history questionnaires designed for clinical use: a systematic review. Public Health Genomics 2009, 12(2):73-83.
39. O'Neill S.M., Rubinstein W.S., Wang C., et al. Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 2009, 36(6):506-514.
40. Acheson L.S., Zyzanski S.J., Stange K.C., et al. Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. JClin Oncol 2006, 24(34):5395-5402.
41. My family health portrait tool. US Surgeon General. Available at:. Accessed November 4, 2013. https://familyhistory.hhs.gov/fhh-web/home.action.
42. Family history 2013, National Human Genome Research Institute, Bethesda (MD), Available at:, Accessed November 4, 2013. http://www.genome.gov/27527640.
43. Family health history. Genetic Alliance. Available at:. Accessed November 4, 2013. http://www.geneticalliance.org/fhh.
44. Family medical history in disease prevention. American Medical Association. Available at:. Accessed November 4, 2013. http://www.ama-assn.org/resources/doc/genetics/family_history02.pdf.
45. Ford D., Easton D.F., Bishop D.T., et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343(8899):692-695.
46. Ford D., Easton D.F., Stratton M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62(3):676-689.
47. Struewing J.P., Hartge P., Wacholder S., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. NEngl J Med 1997, 336(20):1401-1408.
48. Antoniou A., Pharoah P.D., Narod S., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117-1130.
49. Chen S., Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. JClin Oncol 2007, 25(11):1329-1333.
50. SEER cancer statistics review, 1975-2010 2013, National Cancer Institute, Bethesda (MD), Based on November 2012 SEER data submission, posted to the SEER website. Available at:, Accessed November 4, 2013. http://seer.cancer.gov/csr/1975_2010/, N. Howlader, A.M. Noone, M. Krapcho (Eds.).
51. Antoniou A.C., Pharoah P.P., Smith P., et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 2004, 91(8):1580-1590.
52. Myriad Genetic Laboratories, Inc. Mutation prevalence tables. 2010. Availableat:. Accessed August 8, 2013. http://www.myriad.com/lib/brac/brca-prevalence-tables.pdf.
53. Hunt L.M., Kreiner M.J. Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling. Cult Med Psychiatry 2013, 37(1):226-235.
54. Williams D.R. Miles to go before we sleep: racial inequities in health. JHealth Soc Behav 2012, 53(3):279-295.
55. Sorkin D.H., Ngo-Metzger Q., De Alba I. Racial/ethnic discrimination in health care: impact on perceived quality of care. JGen Intern Med 2010, 25(5):390-396.
56. Richardson L.D., Norris M. Access to health and health care: how race and ethnicity matter. Mt Sinai J Med 2010, 77:166-177.
57. National healthcare disparities report 2012. US Department of Health and Human Services. Available at:. Accessed November 4, 2013. http://www.ahrq.gov/research/findings/nhqrdr/nhdr12/nhdr12_prov.pdf.
58. Achieving justice in genomic translation: re-thinking the pathway to benefit 2011, Oxford University Press, New York. W. Burke, K.A. Edwards, S. Goering (Eds.).
59. Race, ethnicity, and language data: standardization for health care quality improvement 2009, The National Academies Press, Washington, DC. C. Ulmer, B. McFadden, D.R. Nerenz, Institute of Medicine (US), Subcommittee on Standardized Collection of Race/Ethnicity Data for Healthcare Quality Improvement (Eds.).
60. Webster's online dictionary: definition: ancestry. Available at:. Accessed August 12, 2013. http://www.websters-online-dictionary.org/definitions/Ancestry.
61. Royal C.D., Novembre J., Fullerton S.M., et al. Inferring genetic ancestry: opportunities, challenges, and implications. Am J Hum Genet 2010, 86(5):661-673.
62. McCavit T.L. Sickle cell disease. Pediatr Rev 2012, 33(5):195-204.
63. Sickle-cell anaemia: report by the secretariat 2005, World Health Organization, Available at:, Accessed November 4, 2013. http://apps.who.int/iris/bitstream/10665/20659/1/B117_34-en.pdf.
64. Vallance H., Ford J. Carrier testing for autosomal-recessive disorders. Crit Rev Clin Lab Sci 2003, 40(4):473-497.
65. McCarthy G.M., Crowe J., McCarthy C.J., et al. Hereditary hemochromatosis: a common, often unrecognized, genetic disease. Cleve Clin J Med 2002, 69(3):224-226. 229-30, 232-3.
66. Arcos-Burgos M., Muenke M. Genetics of population isolates. Clin Genet 2002, 61:233-247.
67. Link C.L., McKinlay J.B. Disparities in the prevalence of diabetes: is it race/ethnicity or socioeconomic status? Results from the Boston Area Community Health (BACH) survey. Ethn Dis 2009, 19(3):288-292.
68. O'Loughlin J. Understanding the role of ethnicity in chronic disease: a challenge for the new millennium. CMAJ 1999, 161(2):152-153.
69. Pearce N., Foliaki S., Sporle A., et al. Genetics, race, ethnicity, and health. BMJ 2004, 328(7447):1070-1072.
70. American Heart Association recommendations for physical activity in adults. Available at:. Accessed August 12, 2013. http://www.heart.org/HEARTORG/GettingHealthy/PhysicalActivity/StartWalking/American-Heart-Association-Recommendations-for-Physical-Activity-in-Adults_UCM_307976_Article.jsp.
71. Mester J.L., Schreiber A.H., Moran R.T. Genetic counselors: your partners in clinical practice. Cleve Clin J Med 2012, 79(8):560-568.
72. Find a genetic counselor. National Society of Genetic Counselors. Available at:. Accessed November 4, 2013. http://nsgc.org/p/cm/ld/fid=164.
73. American College of Medical Genetics and Genomics. Available at:. Accessed November 4, 2013. https://www.acmg.net/ACMG/Terms_and_Conditions/ACMG/Terms_and_Conditions.aspx?redirect=https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService/aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9.
74. Genetic testing registry. Available at:. Accessed November 4, 2013. http://www.ncbi.nlm.nih.gov/gtr/.